国际循环”关注我们，
然后点右上角“…”菜单，选择“设为星标”
编者按：2022年美国经导管心血管治疗学术会议（TCT 2022）将于9月16日-19日在美国波士顿以“线上+线下”的形式拉开帷幕。其中6场最新临床科学研究（LBCS）专场即将公布32项试验结果，赶紧看看有哪些研究吧！
最新临床科学研究（LBCS）
结构性心脏病的最新临床科学：第一部分
北京时间: 9月17日 11:00PM-00:30AM（次日）
经导管主动脉瓣置换术中的脑栓塞保护：PROTECTED TAVR研究
Cerebral Embolic Protection During Transcatheter Aortic Valve Replacement: The PROTECTED TAVR Study
CLASP II D试验：经导管缘对缘修复装置治疗退行性二尖瓣反流的随机比较——临床结局和超声发现
CLASP II D Trial: A Randomized Comparison of Transcatheter Edge-to-Edge Repair Devices for Degenerative Mitral Regurgitation – Clinical Outcomes and Echo Findings
经导管缘对缘修复治疗严重二尖瓣反流合并心源性休克患者：TVT注册研究见解
Transcatheter Edge-to-Edge Repair in Patients With Severe Mitral Regurgitation and Cardiogenic Shock: Insights From the TVT Registry
经导管主动脉瓣置换术治疗小主动脉瓣环：FRANCE-TAVI注册研究结果
Transcatheter Aortic Valve Replacement in Small Aortic Annuli: Results From the FRANCE-TAVI Registry
结构性心脏病的最新临床科学：第二部分
北京时间: 9月18日 02:00AM-03:30AM
自膨式经导管主动脉瓣置换术失败和低衰减瓣叶增厚（HALT）的病理学研究
Pathology of Self-Expanding Transcatheter Aortic Valve Failure and Hypo-Attenuated Leaflet Thickening (HALT)
Amulet IDE研究：Amplatzer™ Amulet™ 左心耳封堵器随机对照试验的3年结果
3-Year Outcomes from the Amplatzer™ Amulet™ Left Atrial Appendage Occluder Randomized Controlled Trial (Amulet IDE)
SCOPE I试验的3年结果：比较ACURATE Neo 与 SAPIEN 3经导管心脏瓣膜系统治疗症状性重度主动脉瓣狭窄患者
Three-Year Outcomes of the Randomized SCOPE I Trial Comparing the ACURATE Neo Versus the SAPIEN 3 Transcatheter Heart Valve System in Patients With Symptomatic Severe Aortic Stenosis
1000多名接受MitraClip™G4治疗患者的当代临床和超声心动图结果：EXPAND G4获批后研究结果
Contemporary Clinical and Echocardiographic Outcomes of 1000+ Patients Treated with MitraClip™ G4: Results from the EXPAND G4 Post Approval Study
PASCAL IID注册研究：经导管缘对缘修复治疗有禁忌风险的退行性二尖瓣反流合并复杂二尖瓣解剖患者的前瞻性注册研究
The PASCAL IID Registry: A Prospective Registry for Transcatheter Edge-to-Edge Repair in Prohibitive Risk Patients With Degenerative Mitral Regurgitation and Complex Mitral Valve Anatomy
梗死后室间隔缺损的经皮或外科治疗：英国登记研究
Percutaneous or Surgical Management of Post-Infarction Ventricular Septal Defects: The United Kingdom National Registry
血管疾病和高血压的最新临床科学：第三部分
北京时间: 9月18日 11:00PM-00:30AM（次日）
血管内超声去肾交感神经术治疗未控制的高血压：随机、假对照RADIANCE II关键试验的主要结果
Endovascular Ultrasound Renal Denervation to Treat Uncontrolled Hypertension: Primary Results of the Randomized, Sham-Controlled RADIANCE II Pivotal Trial
未控制的高血压患者经导管去肾交感神经术治疗后的长期结果：SYMPLICITY HTN-3试验的3年随访
Long-Term Outcomes Following Catheter-Based Renal Denervation in Patients With Uncontrolled Hypertension: 3-year Follow-up of the SYMPLICITY HTN-3 Trial
肺动脉去神经术治疗肺动脉高压：一项随机、假对照试验
Pulmonary Artery Denervation for Pulmonary Arterial Hypertension: A Sham-Controlled Randomised Trial
FLASH研究的全美国队列结果：FlowTriever机械血栓切除术治疗肺栓塞的注册研究
Outcomes for the Full US Cohort of he FLASH FlowTriever Mechanical Thrombectomy Registry in Pulmonary Embolism
心脏手术血管通路的超声引导：一项随机试验（UNIVERSAL研究）
Ultrasound Guidance for Vascular Access for Cardiac Procedures: A Randomized Trial (UNIVERSAL)
结构性心脏病的最新临床科学：第四部分
北京时间: 9月19日 02:00AM-03:30AM
CONFIDENCE登记研究：在经验丰富的TAVI中心植入Portico™瓣膜后的瓣膜血流动力学和1年生存率
CONFIDENCE Registry: Valve Hemodynamics and 1-Year Survival Following Implantation of the PorticoTM Valve in Experienced TAVI Centers
TAVR预后随时间改善的因素：来自STS-ACC TVT注册研究的见解
Mediators of Improvement in TAVR Outcomes Over Time: Insights from the STS-ACC TVT Registry
使用 SAPIEN 3/Ultra 瓣膜对衰败的外科瓣膜进行 TAVR瓣中瓣手术的患者进行生物瓣膜扩裂技术的频率和安全性：真实世界数据
Frequency and Safety of Bioprosthetic Valve Fracture in Patients Undergoing Valve in Valve TAVR for Failed Surgical Valves Using the SAPIEN 3/Ultra Valves: Insights From Real-World Data
既往经导管 vs. 外科主动脉瓣置换术后的外科主动脉瓣置换术风险增加的比较
Increased Risk of Surgical Aortic Valve Replacement After Prior Transcatheter Versus Surgical Aortic Valve Replacement
主动脉瓣置换术后的心脏损伤和生活质量：PARTNER试验的结果
Cardiac Damage and Quality of Life After Aortic Valve Replacement: Results from the PARTNER Trials
经心尖二尖瓣置换术后的中期超声心动图结果：Intrepid Pilot研究的更新结果
Mid-term Echocardiographic Outcomes Following Transapical Mitral Valve Replacement: Updates from the Intrepid Pilot Study
冠状动脉疾病的最新临床科学：第五部分
北京时间: 9月19日 11:00PM-00:30AM（次日）
依维莫司洗脱支架或搭桥手术治疗多支冠状动脉疾病：多中心随机对照BEST试验的10年结果
Everolimus-Eluting Stents or Bypass Surgery for Mutivessel Coronary Artery Disease: 10-Year Outcomes of Multicenter Randomized Controlled BEST Trial
左主干冠状动脉疾病PCI或CABG后的生存率：瑞典冠状动脉血管造影和血管成形术登记处的报告
Survival after PCI or CABG for Left Main Coronary Disease: A Report from the Swedish Coronary Angiography and Angioplasty Registry
一项评估计算机断层扫描冠状动脉造影（CTCA）在提高患者满意度，减少造影剂负荷、手术时间和既往接受CABG患者并发症方面价值的随机对照试验
A Randomised Controlled Trial Assessing The Value Of Computed Tomography Cardiac Angiography (CTCA) In Improving Patient Satisfaction And Reducing Contrast Load, Procedural Duration And Complications In Patients Who Had Previous Bypass Operation (CABG) Undergoing Invasive Coronary Angiography
FAME 3亚组研究：与PCI术后FFR参数的解剖/功能意义与预后价值相关的临床结果
FAME 3 Substudies: Clinical Outcomes Related to Anatomic vs. Functional Significance and Prognostic Value of Post-PCI FFR
血管造影定量流量比引导的冠状动脉介入治疗：FAVOR III中国试验的两年结果
Angiographic Quantitative Flow Ratio-Guided Coronary Intervention: Two-Year Outcomes of the FAVOR III China Trial
冠状动脉疾病的最新临床科学：第六部分
北京时间: 9月20日 02:00AM-03:30AM
ST段抬高型心肌梗死患者PCI后早期常规应用PCSK9抑制剂的随机双盲试验
Randomized, Double-Blind Trial of Routine Early Treatment with PCSK-9 inhibitor in Patients Undergoing Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction
经桡动脉冠脉介入术后使用利伐沙班预防桡动脉闭塞：RIVARAD多中心随机试验
Prevention of Radial Artery Occlusion With Rivaroxaban After Transradial Coronary Procedures: The RIVARAD Multicentric Randomized Trial
钙化冠状动脉血管内碎石术后支架扩张 vs. 常规预扩张的比较
EXpansion of Stents After Intravascular lithoTripsy Versus Conventional Predilatation in CALCified Coronary Arteries
切割球囊优化支架植入前的预扩张：COPS随机试验
Cutting Balloon to Optimize Predilatation for Stent Implantation: The COPS Randomized Trial
急性冠状动脉综合征的潜在原因及直接PCI后的1年结果：光学相干断层扫描引导的PCI治疗的结果（TACTICS 注册研究）
Impact of Underlying Causes of Acute Coronary Syndrome and 1-Year Outcomes After Percutaneous Coronary Intervention: Results From Optical Coherence Tomography Guided Primary Percutaneous Coronary Intervention Registry (TACTICS Registry)
SUGAR随机试验：糖尿病患者第二代药物洗脱支架植入后的2年结果
Two-Year Outcomes Of The Randomized Second-Generation Drug-Eluting Stents In Diabetes (SUGAR) Trial
声明：本文仅供医疗卫生专业人士了解最新医药资讯参考使用，不代表本平台观点。该信息不能以任何方式取代专业的医疗指导，也不应被视为诊疗建议，如果该信息被用于资讯以外的目的，本站及作者不承担相关责任。
（来源：《国际循环》编辑部）
版
权
声
明
凡原创文章版权属《国际循环》所有。欢迎个人转发分享。其他任何媒体、网站如需转载或引用本网版权所有之内容须在醒目位置处注明“转自《国际循环》”
点分享
点收藏
点点赞
点在看
